Exhibit 107

CALCULATION OF FILING FEE TABLE

Form S-8

(Form Type)

Corbus Pharmaceuticals Holdings, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

Security

Type

   

Title of securities  

to be registered  

   

Fee
Calculation  

Rule

   

Amount  

to be  

registered(1)  

   

Proposed  

maximum  

offering price  

per share(2)  

   

Proposed  
maximum  

aggregate  

offering price(2)  

    Fee Rate     

Amount of  

registration  

fee(2)  

     
Equity    Common Stock,
$0.0001 par value per
share		    Other    8,766,162    $0.37    $3,243,480    0.0000927      $301   

Total Offering Amounts

         $3,243,480         $301   

Total Fee Offsets(3)

                   —   

Net Fee Due

                   $301   

 

(1)

Covers 8,766,162 shares of common stock issuable under the Corbus Pharmaceuticals Holdings, Inc. 2014 Equity Compensation Plan (the “2014 Plan”), and, pursuant to Rule 416(c) under the Securities Act of 1933, as amended (the “Securities Act”), an indeterminable number of shares of common stock issuable under the 2014 Plan, as these amounts may be adjusted as a result of stock splits, stock dividends, antidilution provisions, and similar transactions.

(2)

Pursuant to Rules 457(c) and (h) under the Securities Act, the proposed maximum offering price per share and the proposed maximum aggregate offering price are estimated for the purpose of calculating the amount of the registration fee and are based on the average of the high and low sales price of the Registrant’s common stock as reported on the NASDAQ Global Market on March 9, 2022.

(3)

The Registrant does not have any fee offsets.